• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用不同回忆期的患者报告药物不良事件问卷的有效性。

The validity of a patient-reported adverse drug event questionnaire using different recall periods.

作者信息

de Vries Sieta T, Haaijer-Ruskamp Flora M, de Zeeuw Dick, Denig Petra

机构信息

Department of Clinical Pharmacy and Pharmacology (FB20), University of Groningen, University Medical Center Groningen, PO Box 196, 9700 AD, Groningen, The Netherlands.

出版信息

Qual Life Res. 2014 Nov;23(9):2439-45. doi: 10.1007/s11136-014-0715-7. Epub 2014 May 22.

DOI:10.1007/s11136-014-0715-7
PMID:24848596
Abstract

PURPOSE

To assess the validity of a patient-reported adverse drug events (ADEs) questionnaire with a 3-month or 4-week recall period.

METHODS

Patients receiving at least one oral glucose-lowering drug were asked to report potential ADEs they experienced related to any drug in a daily diary for a 3-month period. Thereafter, they completed the ADE questionnaire with either a 3-month or 4-week recall period. The validity was assessed by comparing ADEs reported in each version with those reported in the diary at class level and at specific ADE level. At class level, a comparison was made using (1) primary system organ classes (SOCs) of the medical dictionary for regulatory activities and (2) other related SOCs. Sensitivity and positive predictive value (PPV) were calculated.

RESULTS

Each version of the questionnaire was completed by 39 patients. In the 3-month group, 21 patients reported 70 ADEs in the diary. In the 4-week group, six patients reported seven ADEs in the last 4 weeks of the diary. Sensitivity to assess ADEs at primary SOC was low for both recall groups (33 %). PPV was 51 and 10 % for, respectively, the 3-month and 4-week group. Taking other related SOCs into account slightly increased the sensitivity for the 3-month group (38%). Sensitivity of reporting the same ADE was 41 and 43 % for, respectively, the 3-month and 4-week group.

CONCLUSIONS

Regardless of the recall period and level of comparison, the validity for assessing ADEs was low with the patient-reported ADE questionnaire. Further refinement is needed to improve the validity.

摘要

目的

评估一份回忆期为3个月或4周的患者报告的药物不良事件(ADEs)问卷的有效性。

方法

要求接受至少一种口服降糖药物治疗的患者在一份日常日记中记录他们在3个月内经历的与任何药物相关的潜在ADEs。此后,他们完成回忆期为3个月或4周的ADE问卷。通过比较每个版本报告的ADEs与日记中按类别水平和特定ADE水平报告的ADEs来评估有效性。在类别水平上,使用(1)用于监管活动的医学词典的主要系统器官类别(SOCs)和(2)其他相关SOCs进行比较。计算敏感性和阳性预测值(PPV)。

结果

每个版本的问卷均由39名患者完成。在3个月组中,21名患者在日记中报告了70起ADEs。在4周组中,6名患者在日记的最后4周报告了7起ADEs。两个回忆组在主要SOC评估ADEs的敏感性均较低(33%)。3个月组和4周组的PPV分别为51%和10%。考虑其他相关SOCs后,3个月组的敏感性略有提高(38%)。3个月组和4周组报告相同ADE的敏感性分别为41%和43%。

结论

无论回忆期和比较水平如何,患者报告的ADE问卷评估ADEs的有效性都较低。需要进一步完善以提高有效性。

相似文献

1
The validity of a patient-reported adverse drug event questionnaire using different recall periods.使用不同回忆期的患者报告药物不良事件问卷的有效性。
Qual Life Res. 2014 Nov;23(9):2439-45. doi: 10.1007/s11136-014-0715-7. Epub 2014 May 22.
2
Construct and concurrent validity of a patient-reported adverse drug event questionnaire: a cross-sectional study.患者报告的药物不良事件问卷的结构效度和同时效度:一项横断面研究。
Health Qual Life Outcomes. 2014 Aug 13;12:103. doi: 10.1186/s12955-014-0103-6.
3
Development and Initial Validation of a Patient-Reported Adverse Drug Event Questionnaire.患者报告的药物不良事件问卷的开发与初步验证
Drug Saf. 2013 Sep;36(9):765-77. doi: 10.1007/s40264-013-0036-8.
4
Adverse drug event patterns experienced by patients with diabetes: A diary study in primary care.糖尿病患者经历的药物不良事件模式:一项初级保健中的日记研究。
Pharmacoepidemiol Drug Saf. 2019 Sep;28(9):1175-1179. doi: 10.1002/pds.4839. Epub 2019 Jun 17.
5
Comparing adverse event rates of oral blood glucose-lowering drugs reported by patients and healthcare providers: a post-hoc analysis of observational studies published between 1999 and 2011.比较患者和医疗保健提供者报告的口服降糖药不良事件发生率:1999 年至 2011 年发表的观察性研究的事后分析。
Drug Saf. 2011 Dec 1;34(12):1191-202. doi: 10.2165/11593810-000000000-00000.
6
Performance of the adverse drug event trigger tool and the global trigger tool for identifying adverse drug events: experience in a Belgian hospital.不良药物事件触发工具和全球触发工具在识别不良药物事件中的性能:比利时一家医院的经验。
Ann Pharmacother. 2013 Nov;47(11):1414-9. doi: 10.1177/1060028013500939.
7
Hospital admissions caused by adverse drug events: an Australian prospective study.药物不良事件导致的住院情况:一项澳大利亚前瞻性研究。
Aust Health Rev. 2014 Feb;38(1):51-7. doi: 10.1071/AH12027.
8
Evaluating iatrogenic prescribing: development of an oncology-focused trigger tool.评估医源性处方:开发一种专注于肿瘤学的触发工具。
Eur J Cancer. 2015 Feb;51(3):427-35. doi: 10.1016/j.ejca.2014.12.002. Epub 2014 Dec 27.
9
Prevalence and perceived preventability of self-reported adverse drug events--a population-based survey of 7099 adults.报告的药物不良事件的流行率和可感知的可预防率——一项针对 7099 名成年人的基于人群的调查。
PLoS One. 2013 Sep 4;8(9):e73166. doi: 10.1371/journal.pone.0073166. eCollection 2013.
10
Performance of different data sources in identifying adverse drug events in hospitalized patients.不同数据源在识别住院患者药物不良事件中的表现。
Eur J Clin Pharmacol. 2011 Sep;67(9):909-18. doi: 10.1007/s00228-011-1020-9. Epub 2011 Mar 11.

引用本文的文献

1
Does recall period matter? Comparing PROMIS physical function with no recall, 24-hr recall, and 7-day recall.回忆期是否重要?比较 PROMIS 身体机能与无回忆、24 小时回忆和 7 天回忆。
Qual Life Res. 2020 Mar;29(3):745-753. doi: 10.1007/s11136-019-02344-0. Epub 2019 Nov 7.
2
Adverse drug event patterns experienced by patients with diabetes: A diary study in primary care.糖尿病患者经历的药物不良事件模式:一项初级保健中的日记研究。
Pharmacoepidemiol Drug Saf. 2019 Sep;28(9):1175-1179. doi: 10.1002/pds.4839. Epub 2019 Jun 17.
3
Recommendations on the Use of Mobile Applications for the Collection and Communication of Pharmaceutical Product Safety Information: Lessons from IMI WEB-RADR.

本文引用的文献

1
Comparing patient and parent recall of 90-day and 30-day migraine disability using elements of the PedMIDAS and an Internet headache diary.使用 PedMIDAS 的要素和互联网头痛日记比较患者和家长对 90 天和 30 天偏头痛残疾的回忆。
Cephalalgia. 2014 Apr;34(4):298-306. doi: 10.1177/0333102413508240. Epub 2013 Oct 14.
2
Development and Initial Validation of a Patient-Reported Adverse Drug Event Questionnaire.患者报告的药物不良事件问卷的开发与初步验证
Drug Saf. 2013 Sep;36(9):765-77. doi: 10.1007/s40264-013-0036-8.
3
Choice of recall period for patient-reported outcome (PRO) measures: criteria for consideration.
移动应用程序在药品安全信息收集和交流方面的使用建议:来自 IMI WEB-RADR 的经验教训。
Drug Saf. 2019 Apr;42(4):477-489. doi: 10.1007/s40264-019-00813-6.
4
Interest in a Mobile App for Two-Way Risk Communication: A Survey Study Among European Healthcare Professionals and Patients.对双向风险沟通移动应用程序的兴趣:一项针对欧洲医疗保健专业人员和患者的调查研究。
Drug Saf. 2018 Jul;41(7):697-712. doi: 10.1007/s40264-018-0648-0.
5
Eliciting adverse effects data from participants in clinical trials.从临床试验参与者中获取不良反应数据。
Cochrane Database Syst Rev. 2018 Jan 16;1(1):MR000039. doi: 10.1002/14651858.MR000039.pub2.
6
Factors Influencing the Use of a Mobile App for Reporting Adverse Drug Reactions and Receiving Safety Information: A Qualitative Study.影响使用移动应用报告药物不良反应及接收安全信息的因素:一项定性研究
Drug Saf. 2017 May;40(5):443-455. doi: 10.1007/s40264-016-0494-x.
患者报告结局(PRO)测量的回顾期选择:考虑标准。
Qual Life Res. 2012 Aug;21(6):1013-20. doi: 10.1007/s11136-011-0003-8. Epub 2011 Sep 10.
4
Accuracy of patients' recall of temporomandibular joint pain and dysfunction after experiencing whiplash trauma: a prospective study.患者对经历过挥鞭样损伤后的颞下颌关节疼痛和功能障碍的回忆准确性:一项前瞻性研究。
J Am Dent Assoc. 2010 Jul;141(7):879-86. doi: 10.14219/jada.archive.2010.0287.
5
Interference with activities due to pain and fatigue: accuracy of ratings across different reporting periods.因疼痛和疲劳导致的活动干扰:不同报告期内评分的准确性。
Qual Life Res. 2010 Oct;19(8):1163-70. doi: 10.1007/s11136-010-9681-x. Epub 2010 Jun 11.
6
Time to listen: a review of methods to solicit patient reports of adverse events.倾听的时机:征集患者不良事件报告方法的综述
Qual Saf Health Care. 2010 Apr;19(2):148-57. doi: 10.1136/qshc.2008.030114.
7
Methodological issues affecting the value of patient-reported outcomes data.影响患者报告结局数据价值的方法学问题。
Expert Rev Pharmacoecon Outcomes Res. 2002 Apr;2(2):119-28. doi: 10.1586/14737167.2.2.119.
8
Impact of comorbid conditions and race/ethnicity on glycemic control among the US population with type 2 diabetes, 1988-1994 to 1999-2004.2008 年至 2012 年期间美国 2 型糖尿病患者的合并症和种族/民族对血糖控制的影响。
J Diabetes Complications. 2010 Nov-Dec;24(6):382-91. doi: 10.1016/j.jdiacomp.2009.07.001. Epub 2009 Aug 27.
9
Optimal recall periods for patient-reported outcomes: challenges and potential solutions.患者报告结局的最佳回忆期:挑战与潜在解决方案。
Curr Med Res Opin. 2009 Apr;25(4):929-42. doi: 10.1185/03007990902774765.
10
The accuracy of pain and fatigue items across different reporting periods.不同报告期内疼痛和疲劳项目的准确性。
Pain. 2008 Sep 30;139(1):146-157. doi: 10.1016/j.pain.2008.03.024. Epub 2008 May 1.